Mostrar el registro completo del ítem
Gasent Blesa, JM.; Giner Marco, V.; Giner-Bosch, V.; Cerezuela Fuentes, P.; Alberola Candel, V. (2011). Phase II Trial of Oxaliplatin and Capecitabine After Progression to First-Line Chemotherapy in Androgen-Independent Prostate Cancer Patients. American Journal of Clinical Oncology. 34(2):1-5. https://doi.org/10.1097/COC.0b013e3181d6b453
Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/139762
Título: | Phase II Trial of Oxaliplatin and Capecitabine After Progression to First-Line Chemotherapy in Androgen-Independent Prostate Cancer Patients | |
Autor: | Gasent Blesa, J. M. Giner Marco, V. Cerezuela Fuentes, Pablo Alberola Candel, Vicente | |
Entidad UPV: |
|
|
Fecha difusión: |
|
|
Resumen: |
[EN] Introduction: Docetaxel plus prednisone is the current standard of care in first-line chemotherapy for metastatic hormone-refractory prostate cancer. However, there is no agent proven as effective after progression ...[+]
|
|
Palabras clave: |
|
|
Derechos de uso: | Cerrado | |
Fuente: |
|
|
DOI: |
|
|
Editorial: |
|
|
Versión del editor: | https://doi.org/10.1097/COC.0b013e3181d6b453 | |
Tipo: |
|